Fidaxomicin in the Treatment of Clostridium difficile-Associated Diarrhoea

被引：0
作者：
Sclar, David Alexander [1 ]
Robison, Linda M. [1 ]
Oganov, Ambartsum M. [1 ]
Schmidt, Jennifer M. [1 ]
Bowan, Kurt A. [1 ]
Castillo, Leigh V. [1 ]
机构：
[1] Midwestern Univ, Coll Pharm, Glendale, AZ USA
来源：
CLINICAL DRUG INVESTIGATION | 2013年 / 33卷 / 03期
关键词：
Public Health; Internal Medicine; Vancomycin; Healthcare System; Metronidazole;
D O I：
10.1007/s40261-013-0059-z
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：229 / 229
页数：1
相关论文
共 50 条
  • [41] The role of acute care surgery in the treatment of severe, complicated Clostridium difficile-associated disease
    Carchman, Evie H.
    Peitzman, Andrew B.
    Simmons, Richard L.
    Zuckerbraun, Brian S.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2012, 73 (04) : 789 - 800
  • [42] Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection
    Zhanel, George G.
    Walkty, Andrew J.
    Karlowsky, James A.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2015, 26 (06) : 305 - 312
  • [43] Is clostridium difficile-associated disease really changing?
    Laing, R. B. S.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2005, 35 (03) : 226 - 226
  • [44] Fidaxomicin inhibits toxin production in Clostridium difficile
    Babakhani, Farah
    Bouillaut, Laurent
    Sears, Pamela
    Sims, Carlee
    Gomez, Abraham
    Sonenshein, Abraham L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 515 - 522
  • [45] Clostridium difficile-associated colitis: Part 2: Therapy and prevention
    Markus P.M.
    coloproctology, 2012, 34 (6) : 447 - 455
  • [46] Imipenem/cilastatinClostridium difficile-associated diarrhoea in an elderly patient: case report
    Reactions Weekly, 2011, 1371 (1) : 20 - 20
  • [47] The impact of pseudomembrane formation on the outcome of Clostridium difficile-associated disease
    Berdichevski, T.
    Keller, N.
    Rahav, G.
    Bar-Meir, S.
    Eliakim, R.
    Ben-Horin, S.
    INFECTION, 2013, 41 (05) : 969 - 977
  • [48] Past, present, and future therapies for Clostridium difficile-associated disease
    Surowiec, Dorothy
    Kuyumjian, Arpi G.
    Wynd, Michael A.
    Cicogna, Cristina E.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (12) : 2155 - 2163
  • [49] Fidaxomicin: A Novel Macrocyclic Antibiotic Approved for Treatment of Clostridium difficile Infection
    Venugopal, Anilrudh A.
    Johnson, Stuart
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (04) : 568 - 574
  • [50] Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial
    O'Gorman, Molly A.
    Michaels, Marian G.
    Kaplan, Sheldon L.
    Otley, Anthony
    Kociolek, Larry K.
    Hoffenberg, Edward J.
    Kim, Kwang Sik
    Nachman, Sharon
    Pfefferkorn, Marian D.
    Sentongo, Timothy
    Sullivan, Janice E.
    Sears, Pamela
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2018, 7 (03) : 210 - 218
12345